Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
OXBT > SEC Filings for OXBT > Form 8-K on 6-Mar-2014All Recent SEC Filings

Show all filings for OXYGEN BIOTHERAPEUTICS, INC.

Form 8-K for OXYGEN BIOTHERAPEUTICS, INC.


6-Mar-2014

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On February 28, 2014, Oxygen Biotherapeutics, Inc. (the "Company") was orally notified by the U.S. Food and Drug Administration (the "FDA") that the agency has completed its review of the Company's September 2013 nonclinical submission and has lifted the clinical hold on Oxycyte.

On March 4, 2014, the Company issued a press release regarding the FDA action described above. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.   Description

  99.1        Press Release dated March 4, 2014.


  Add OXBT to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for OXBT - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.